RWS Holdings plc (LON:RWS – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 160.19 ($2.03) and traded as low as GBX 127.60 ($1.62). RWS shares last traded at GBX 128 ($1.62), with a volume of 389,750 shares trading hands.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the stock. Shore Capital reaffirmed a “buy” rating on shares of RWS in a report on Thursday, December 12th. Berenberg Bank reiterated a “buy” rating and set a GBX 330 ($4.19) price target on shares of RWS in a research report on Thursday, December 12th.
Read Our Latest Analysis on RWS
RWS Stock Down 2.0 %
RWS (LON:RWS – Get Free Report) last issued its quarterly earnings results on Thursday, December 12th. The company reported GBX 21.60 ($0.27) earnings per share for the quarter. RWS had a negative return on equity of 4.15% and a negative net margin of 5.22%. As a group, research analysts predict that RWS Holdings plc will post 10.6469761 earnings per share for the current fiscal year.
RWS Increases Dividend
The company also recently disclosed a dividend, which was paid on Friday, February 14th. Investors of record on Thursday, January 16th were paid a GBX 9.80 ($0.12) dividend. This is a positive change from RWS’s previous dividend of $2.40. The ex-dividend date was Thursday, January 16th. This represents a yield of 3.96%. RWS’s dividend payout ratio (DPR) is currently -119.36%.
About RWS
RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language.
Our purpose is unlocking global understanding.
See Also
- Five stocks we like better than RWS
- Stock Analyst Ratings and Canadian Analyst Ratings
- These Consumer Staples Shine Amid Market Turmoil
- The 3 Best Blue-Chip Stocks to Buy Now
- Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
- Stock Sentiment Analysis: How it Works
- Axon: Long-Term Outlook Is Strong Despite Federal Budget Worries
Receive News & Ratings for RWS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RWS and related companies with MarketBeat.com's FREE daily email newsletter.